Targeting the ChREBP/PKLR-lactate axis via Huachansu tablets restores CD8⁺T cell immunity in MASH-HCC.
- DOI
- 10.1016/j.phrs.2026.108448
- Published
- 2026 Sep 14
- Container
- Pharmacological research
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.phrs.2026.108448,
title = {Targeting the ChREBP/PKLR-lactate axis via Huachansu tablets restores CD8⁺T cell immunity in MASH-HCC.},
author = {Li Y and Ma J and Peng W and Lv Z and Liang X and Li S and Wang M and Su J and Luo S and Gu W and Cheng H and Luo C and Wang M and Li Q},
year = {2026},
journal = {Pharmacological research},
doi = {10.1016/j.phrs.2026.108448},
url = {https://doi.org/10.1016/j.phrs.2026.108448}
}RIS
TY - JOUR TI - Targeting the ChREBP/PKLR-lactate axis via Huachansu tablets restores CD8⁺T cell immunity in MASH-HCC. AU - Li Y AU - Ma J AU - Peng W AU - Lv Z AU - Liang X AU - Li S AU - Wang M AU - Su J AU - Luo S AU - Gu W AU - Cheng H AU - Luo C AU - Wang M AU - Li Q PY - 2026 JO - Pharmacological research DO - 10.1016/j.phrs.2026.108448 UR - https://doi.org/10.1016/j.phrs.2026.108448 ER -
APA
Y, L., J, M., W, P., Z, L., X, L., S, L., M, W., J, S., S, L., W, G., H, C., C, L., M, W., & Q, L. (2026). Targeting the ChREBP/PKLR-lactate axis via Huachansu tablets restores CD8⁺T cell immunity in MASH-HCC.. Pharmacological research. https://doi.org/10.1016/j.phrs.2026.108448
Source records
- pubmed · retrieved 2026-09-26T04:53:47.954Z